Parkinson's Disease clinical trials
Showing 201–250 of 314 active trials. Describe your situation to see which ones look like a fit.
- Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease
- Action Regulation Behavioral
- Personalized Real-Time DBS and PD Mechanisms
- Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
- Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
- Understanding Motivation in Parkinson's Patients Through Neurophysiology
- Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
- Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease
- Attention and Eye Movement in Parkinson's Disease
- Sleep-specific DBS Therapy in Parkinson's Disease
- Neurophysiology of Reward Signaling in Parkinson's Disease
- Exercise Neuroprotection in Parkinson's Disease
- Online Motor Control in People With Parkinson's Disease
- The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
- Virtual Cycling Environments for Persons With Parkinson Disease
- Cortical-Basal Ganglia Speech Networks
- PET Imaging Evaluation of [11C]SY08
- Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
- User-friendliness of a Portable Driving Simulator
- [18F]F-DOPA Imaging in Patients With Autonomic Failure
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Cerebellar Stimulation and Cognitive Control
- Our Peers - Empowerment and Navigational Support - Community Living: Remote Peer Navigator Intervention for Adults With Newly Acquired Disabilities Transitioning to Community Living (OP-ENS -CL)
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- Voiceitt for People With Impairments in Speech
- Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
- Passive Versus Active Music Therapy Parkinson's Disease
- Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
- Prescriptive Infusion Algorithm (PIA)
- Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
- Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients
- Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population
- AAV2-hAADC for Parkinson's Disease (PDCS-01)
- Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
- iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
- Low-Fidelity Driving Simulator Training in Parkinson's Disease.
- A System to Help With Freezing of Gait in Parkinson's Patients
- Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study
- VC/VS for Apathy in PD
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
- SwallowFIT Study in Parkinson's Disease
- Smartshoes for Freezing of Gait in Parkinson's Disease
- Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease
- Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
- Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.